NASDAQ: EIKN

How many employees work at Eikon Therapeutics?

Eikon Therapeutics, Inc. (EIKN) has approximately 397 total employees worldwide as of December 2025, according to Revelio Labs workforce intelligence data. Eikon Therapeutics's total headcount has grown 22.8% from 323 employees in 2023 to 397 in 2025.

Data source: Revelio LabsCoverage: Global workforce, 2023–2026Published June 2026

Eikon Therapeutics is hiring

Is Eikon Therapeutics hiring right now?

Yes, Eikon Therapeutics is actively hiring. Eikon Therapeutics had 52 active job postings in 2025, a 60.0% increase from 2024 see job openings & hiring trends.

About Eikon Therapeutics's Workforce

Eikon Therapeutics, Inc. (EIKN) is a Biotech and Healthcare Services company that employs 397 people worldwide as of December 2025. It is the 5th-largest by headcount among its peers. Founded in 2019, the company is headquartered in Millbrae, California and trades on the NASDAQ.

Eikon Therapeutics's workforce has grown 22.8% from 2023 to 2025, though it is down 7.6% year over year in 2025. Its workforce is concentrated most in the United States (98.1%), followed by Denmark (0.5%) and Australia (0.5%), with Denmark, its fastest-growing location, up 100.0%.

Eikon Therapeutics's largest functional groups are Finance and Operations (47.3%), Engineering (32.9%), and Sales and Marketing (19.8%). Median employee tenure is 2.3 years. The average salary is $190,314, highest in Northern America at a median of $167,000.

Eikon Therapeutics's active job postings rose 60.0% in 2025 to 52, with new postings per month cooling from 61 in 2023 to 23 in 2025. Overall employee sentiment is negative and declining.

Sourced from Revelio Labs workforce data.

As of December 2025

Eikon Therapeutics
workforce metrics

Headcount

397

7.6% YoY

Avg. Salary

$190.3k

1.5% YoY

Tenure

2.3yr

0.2yr YoY

Growth Rate

-7.6%

17.3pts YoY

Hiring Rate

Attrition Rate

Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Eikon Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.

Unlock Metrics
Interactive chart of Eikon Therapeutics annual worldwide employee count from 2023 to 2025.
  • Eikon Therapeutics had 397 employees in 2025, a 7.6% decline (-31) from 2024.
  • Eikon Therapeutics had 428 employees in 2024, a 9.7% increase (+40) from 2023.
  • Eikon Therapeutics had 388 employees in 2023, a 33.0% increase (+110) from 2022.

Eikon Therapeutics's total workforce has grown from 323 employees in 2023 to 397 in 2025.

Eikon Therapeutics, Inc. — quarterly employee count (20232025)

YearQtrEmployeesYoY ChangeYoY %
2025Q4397-31-7.6%
2025Q3399-14-3.5%
2025Q2429+16+3.9%
2025Q1434+40+9.5%
2024Q4428+40+9.7%
2024Q3413+18+4.5%
2024Q2413+40+10.0%
2024Q1394+71+20.0%
2023Q4388+110+33.0%
2023Q3395+148+45.9%
2023Q2373+173+60.4%
2023Q1323+168+70.4%

Want to see Eikon Therapeutics's complete headcount history back to 2017, including quarterly breakdowns?

Get the Data

The United States accounts for the largest share of Eikon Therapeutics's global workforce with approximately 98% of total employees, followed by Denmark and Australia. Eikon Therapeutics's headcount in Denmark is growing fastest among its major locations, up 100.0% year over year in 2025.

Eikon Therapeutics employees by country — 2025

CountryEmployees% of TotalYoY %
United States39098.1%-7.4%
Denmark20.5%+100.0%
Australia20.5%+100.0%
Canada10.4%+100.0%
United Kingdom10.3%+0.0%
Italy10.3%+0.0%

Drill into city-level data, hiring trends by region and historic geographic shifts

Unlock Geographic Data

Eikon Therapeutics's largest employee groups are Finance and Operations (47.3%), Engineering (32.9%), and Sales and Marketing (19.8%).

Eikon Therapeutics employees by department — 2025

DepartmentEmployees% of TotalYoY %
Finance and Operations18847.3%-3.9%
Engineering13132.9%-9.3%
Sales and Marketing7919.8%-7.6%

Compare Eikon Therapeutics's department mix to industry peers.

See Full Data

Eikon Therapeutics's average employee salary is $190,314 globally. Employees in Northern America receive the highest compensation.

Eikon Therapeutics median employee salary by region — 2025 (USD)

RegionMedian Salary
Northern America$167,000

Unlock salary by role, level, and city — and compare to Eikon Therapeutics's industry peers.

Unlock Salary Data
Interactive chart of Eikon Therapeutics annual active job postings from 2023 to 2025.
  • Eikon Therapeutics had 52 active job postings in 2025, a 60.0% increase (+24) from 2024.
  • Eikon Therapeutics had 28 active job postings in 2024, a 52.6% decline (-20) from 2023.
  • Eikon Therapeutics had 48 active job postings in 2023, a 59.9% decline from 2022.
  • Hiring velocity in 2025: 23 new roles/month, down from 29 in 2024 and 61 in 2023. New metric

Eikon Therapeutics's active job postings rose 60.0% in 2025 to 52, with new postings per month cooling from 61 in 2023 to 23 in 2025.

Track new postings per month, role-level demand, and hiring velocity vs. peers.

Unlock Hiring Data

Revelio Labs tracks employee sentiment across Eikon Therapeutics's workforce based on public professional data. Overall sentiment is negative and has declined year over year in 2025.

Overall

NegativePositive

Unlock the full sentiment breakdown by department, tenure, and trend over time.

Unlock Sentiment
How fast is Eikon Therapeutics growing?
In 2025, Eikon Therapeutics's headcount shrank 7.6% to 397 employees, down from 428 in 2024.
Where are Eikon Therapeutics employees located?
Most Eikon Therapeutics employees are based in the United States (98.1% of headcount), followed by Denmark and Australia.
What is the average salary at Eikon Therapeutics?
The average employee salary at Eikon Therapeutics is approximately $190.3k per year.
How many people does Eikon Therapeutics hire per year?
In 2025, Eikon Therapeutics opened roughly 276 new roles — about 23 per month.
When was Eikon Therapeutics founded and where is it headquartered?
Eikon Therapeutics was founded in 2019 and is headquartered in Millbrae, California.

See something that doesn't look right? Reach out and our team will review it.